I will be nominating Christopher A. Wray, a man of impeccable credentials, to be the new Director of the FBI. Details to follow.
— Donald J. Trump (@realDonaldTrump) June 7, 2017
Who is Christopher A. Wray?
Well, he’s a litigation partner in King & Spalding’s Washington DC and Atlanta office.
And who, I hear you ask, are King & Spalding?
Well, they’re the law firm who just got spanked in Chicago. They defended GlaxoSmithKline, arguing that their antidepressant, Paxil, did not cause the suicide of Stewart Dolin.
The jury saw through the weak defence and found Glaxo liable.
Prior to joining the firm, Wray served from 2003 to 2005 as the Assistant Attorney General in charge of the U.S. Department of Justice’s (DOJ) Criminal Division, the same department who, in 2012, slammed down a $3 billion fine after GlaxoSmithKline pleaded guilty to a whole host of federal crimes.
So, what duties does one who becomes director at the FBI have to carry out?
Well, he’s basically responsible for its day-to-day operations.
The FBI has jurisdiction over violations of more than 200 categories of federal crimes.
So nice to know that one of King & Spalding’s biggest and wealthiest clients, GlaxoSmithKline, may now have someone to oversee any future criminal behaviour of theirs.
This shit just writes itself.
Nice move, Don.